0.5501
Schlusskurs vom Vortag:
$0.65
Offen:
$0.65
24-Stunden-Volumen:
323.90K
Relative Volume:
3.77
Marktkapitalisierung:
$4.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.44M
KGV:
-0.0343
EPS:
-16.0242
Netto-Cashflow:
$-28.30M
1W Leistung:
-36.03%
1M Leistung:
-31.24%
6M Leistung:
-69.27%
1J Leistung:
-85.56%
Nucana Plc Adr Stock (NCNA) Company Profile
Vergleichen Sie NCNA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NCNA
Nucana Plc Adr
|
0.5501 | 4.78M | 0 | -33.44M | -28.30M | -16.02 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
493.84 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
602.64 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
614.76 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
251.56 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
244.90 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-30 | Herabstufung | William Blair | Outperform → Mkt Perform |
2022-03-03 | Herabstufung | Cowen | Outperform → Market Perform |
2020-10-22 | Eingeleitet | Truist | Buy |
2020-07-24 | Eingeleitet | Oppenheimer | Outperform |
2019-08-19 | Eingeleitet | H.C. Wainwright | Buy |
2018-10-19 | Eingeleitet | Piper Jaffray | Overweight |
2017-10-23 | Eingeleitet | Citigroup | Buy |
2017-10-23 | Eingeleitet | Jefferies | Buy |
2017-10-23 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Nucana Plc Adr Aktie (NCNA) Neueste Nachrichten
NCNA’s Stock Journey: What Investors Need to Know About NuCana plc ADR’s Performance - investchronicle.com
Do investors need to be concerned about Cadiz Inc (CDZI)? - uspostnews.com
Natera Inc (NTRA) deserves closer scrutiny - uspostnews.com
Weave Communications Inc (WEAV) produces promising results - uspostnews.com
Investing in NuCana plc ADR (NCNA) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? - Yahoo Finance
Post-Trade Analysis: NuCana plc ADR (NCNA) Slides -26.97, Closing at 0.65 - DWinneX
Closing Bell Recap: Yxt.Com Group Holding Ltd. ADR (YXT) Ends at 0.56, Reflecting a -14.42 Downturn - DWinneX
In the Green: Gogoro Inc (GGR) Closes at 0.26, Up/Down 0.08 from Previous Day - DWinneX
Daily Market Movement: Tivic Health Systems Inc (TIVC) Sees a 1.88 Increase, Closing at 7.04 - DWinneX
RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks - Barchart.com
Stock Update - Investorsobserver
NuCana Reports Strong Phase 2 Data: 75% Disease Control in Melanoma Trial, Lower Q3 Loss - StockTitan
Get in on NuCana plc ADR’s (NCNA) buy-in window today! - SETE News
NuCana plc ADR Inc. (NCNA) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Daily Market Movement: NuCana plc ADR (NCNA) Sees a -7.03 Decrease, Closing at 3.44 - The Dwinnex
NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study - Yahoo Finance
Oppenheimer slashes NuCana stock target, remains Outperform on optimism for upcoming trials - Investing.com
NuCana Ends Phase 2 Cancer Study, Focuses on Promising Treatments - TipRanks
NuCana shares receive $150 stock PT at Oppenheimer on upbeat trial prospects - Investing.com
NuCana plc Announces Reverse ADS Split - TipRanks
NuCana: Potential Turnaround In 2024 But Risky - Seeking Alpha
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
Will NuCana Continue to Surge Higher? - Nasdaq
NCNA Stock Price and Chart — NASDAQ:NCNA - TradingView
NuCana PLC Stock Price Today | NASDAQ: NCNA Live - Investing.com
Finanzdaten der Nucana Plc Adr-Aktie (NCNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):